<DOC>
	<DOCNO>NCT00255229</DOCNO>
	<brief_summary>Irinotecan ( 7-ethyl-10- { 4 ( -1-piperidino ) -1-piperidino } carbonyloxy camptothecin ) semisynthetic camptothecin derivative introduce 1980 's . Irinotecan prodrug metabolize carboxylesterases active metabolite 7-ethyl-10-hydroxy-camptothecin ( SN38 ) . SN38 exert cytotoxic effect form stable complex topoisomerase I DNA . These complex collide replication fork cause break DNA . Studies substantiate irinotecan 's activity 5FU resistant colorectal cancer lead approval treatment 5FU resistant colorectal cancer United States , Canada Europe.Colorectal cancer study demonstrate single agent irinotecan 's dose limit toxicity diarrhea occur 5 6 day administration . High dose loperamide first occurrence diarrhea decrease incidence diarrhea incidence grade 3/4 diarrhea remain high 28 40 % .</brief_summary>
	<brief_title>Study Glutamine Prophylaxis Irinotecan Induced Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<criteria>metastatic colorectal cancer treat FOLFIAT chemo severely abnormal liver kidney function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>irinotecan</keyword>
	<keyword>5FU</keyword>
	<keyword>amino acid</keyword>
	<keyword>heat shock protein</keyword>
</DOC>